It was standing-room only at the main stages of NHS England's Health and Care Innovation Expo 2018 Sept. 5 as NHS chief executive Simon Stevens reeled off recent examples of patient-care innovations.
Attracting the most attention was the approval of the ground-breaking cancer treatment for children and young people, the CAR-T cell therapy Kymriah, from Novartis AG. Announced by the NHS...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?